MorphoSys AG - Articles and news items

MorphoSys provides update on MOR202 in multiple myeloma

Industry news / 23 September 2015 / Victoria White

The Company said that the clinical data from a Phase 1/2a study confirm the very good overall safety profile of the fully human HuCAL antibody…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+